700 projects

SYSTEMET-INT-SYSTEMET-INT

Understanding and preventing violence in high risk individuals– a mixed-methods approach (PreVio)

Violent crime committed by persons with severe mental illness represent an area of shared responsibility between the criminal justice system and the health services, with interconnected challenges: fatal incidents perpetrated by persons with a known history of mental illness and violence, a cons...

Awarded: NOK 75,999

Project Period: 2025-2026

Location: Oslo

HELSEFORSKNING-Helseforskning

Developing KNOWledge on needs and MEasures aimed at children experiencing parental problem gambling

Problem gambling is a global public health concern with serious consequences for individuals and their families. Shame and stigma often lead to underreporting, and for each person with severe gambling problems, an estimated six close relatives are significantly affected—children being especially ...

Awarded: NOK 9.7 mill.

Project Period: 2025-2029

Location: Akershus

FRIPROSJEKT-FRIPROSJEKT

Exploring novel therapies for celiac disease centered around the autoantigen transglutaminase 2

Celiac disease is affecting 1-2% of the population. Today the only existing treatment for the widespread disorder is a lifelong gluten-free diet. There is a need to develop alternative treatments. Recent research has revealed that the enzyme transglutaminase 2 plays a central role in the developm...

Awarded: NOK 12.0 mill.

Project Period: 2025-2028

Location: Oslo

HELSEFORSKNING-Helseforskning

Mechanisms of Persistent Fatigue

Persistent fatigue (PF) is a highly prevalent transdiagnostic symptom. Acute infection is a common trigger of PF, as exemplified by ‘Long COVID’ . PF is an under-researched field, with scarce knowledge of disease mechanisms as well as treatment and preventive measures. Existing knowledge on PF s...

Awarded: NOK 4.5 mill.

Project Period: 2025-2028

Location: Akershus

FORSKNINGSINFRA-FORSKNINGSINFRA

ATMP Norway. A multi-nodal infrastructure for Advanced Therapy Medicinal Products in Norway.

ATMP Norway: A National Infrastructure for Advanced Therapies Advanced Therapy Medicinal Products (ATMPs) offer curative potential by targeting the underlying biology of diseases such as cancer, autoimmunity, and genetic disorders. CAR-T cell therapy has demonstrated clinical success in B cell ma...

Awarded: NOK 50.0 mill.

Project Period: 2025-2035

Location: Oslo

INNO-NAERING-INNO-NAERING

Myocardial and ventricular work symposium

The Myocardial and Ventricular Work Symposium is a two-day event that aims to promote research-based innovation in cardiovascular diagnostics by bringing together academic researchers, clinicians, and industry partners. The symposium will focus on the clinical and industrial applications of a pat...

Awarded: NOK 67,696

Project Period: 2025-2025

Location: Oslo

HELSEFORSKNING-Helseforskning

Human avatar on chip for advancing personalized cancer therapies by integrating vascular and immune components in a Tumor-on-Chip model

Background/rationale: Despite advances in breast cancer therapies, certain tumors remain lethal due to their ability to evade immune system attacks. This immune evasion is strongly influenced by the tumor microenvironment (TME), which includes tumor endothelial cells (TECs), immune cells, and ca...

Awarded: NOK 3.5 mill.

Project Period: 2025-2028

Location: Oslo

NYSKAPNING-NYSKAPNING

Development of an inhaled tankyrase inhibitor for idiopathic pulmonary fibrosis therapy

Fighting Lung Scarring with a New Inhaled Therapy Idiopathic Pulmonary Fibrosis (IPF) is a serious and fatal lung disease that causes progressive scarring of the lungs, making it increasingly difficult to breathe. With no cure and limited treatment options, people diagnosed with IPF face a median...

Awarded: NOK 5.0 mill.

Project Period: 2025-2027

Location: Oslo

HELSEFORSKNING-Helseforskning

Interrogation of the immune-microenvironment of T-cell malignancies

Mature T-cell leukemias/lymphomas (MaTCL) represent a heterogenous group of tumors with predominantly dismal prognoses due to limited efficacy of available treatments. Single MaTCL subtypes are rare, impeding large-volume biomaterial and data collection, and clinical studies. Therapies aimed sole...

Awarded: NOK 3.4 mill.

Project Period: 2025-2028

Location: Oslo

NYSKAPNING-NYSKAPNING

A new antibody design for induced agonism

...

Awarded: NOK 0.50 mill.

Project Period: 2025-2025

Location: Oslo

NYSKAPNING-NYSKAPNING

Smartsock: Market needs and user requirements

One of the most common complications of diabetes is peripheral neuropathy. This involves damage to the nerves and often begins in the feet. Currently, it is challenging to timely detect peripheral neuropathy, as it often begins without symptoms and the most available tests have low accuracy for d...

Awarded: NOK 0.50 mill.

Project Period: 2025-2026

Location: Oslo

NANOTEKNOLOGI-NANOTEKNOLOGI

Combating colorectal peritoneal metastases by a sustained release triple radio-immunotherapy

Peritoneal metastases, which are cancer cells spreading in the abdominal cavity, are difficult to treat and usually mean a poor outlook. Traditional chemotherapy doesn't work well, and we therefore need new treatments that target the cancer directly and minimize side effects. We are developing a ...

Awarded: NOK 3.7 mill.

Project Period: 2025-2028

Location: Oslo

NANOTEKNOLOGI-NANOTEKNOLOGI

Actuating nanostructured polymer microcarriers for pluripotent stem-cell derived cardiomyocyte expansion and maturation

Heart disease is the number one cause of death worldwide. While treatments have improved, they still don't fix the main problem – the loss of healthy heart muscle cells after damage. To truly repair the heart, we need new therapies that can replace these lost cells with strong, fully working ones...

Awarded: NOK 2.2 mill.

Project Period: 2025-2028

Location: Oslo

HELSEFORSKNING-Helseforskning

Chronic lymphocytic leukemia: Improving survival and quality of life

Chronic lymphocytic leukemia (CLL) is the most common form of leukemia in Europe and it remains incurable. Targeted therapies have revolutionized the treatment of CLL. However, many patients develop resistance, have severe side effects, or relapse during treatment. To prevent ineffective treat...

Awarded: NOK 4.6 mill.

Project Period: 2025-2028

Location: Oslo

FRIPROSJEKT-FRIPROSJEKT

Tankyrase Inhibition in Metastatic Melanoma Immunotherapy

Immunotherapy with immune checkpoint inhibitors has transformed the treatment landscape for melanoma. However, a significant portion of patients (40-65%) do not respond to this therapy due to resistance mechanisms, particularly those driven by the WNT/ß-catenin cell signaling pathway. This resist...

Awarded: NOK 12.0 mill.

Project Period: 2025-2028

Location: Oslo

HELSEFORSKNING-Helseforskning

Risiko for tilbakefall: en KI-basert modell for brystkreftpasienter

Pilot helse forprosjektet Vi vil i forprosjektet diskutere hvilke aktører som er nødvedige å ha med i hovedprosjektet. Forskningsprosjektet Brystkreft er den mest diagnostiserte krefttypen blant kvinner globalt. Til tross for fremskritt i behandlingen, er risikoen for tilbakefall fortsatt en...

Awarded: NOK 0.15 mill.

Project Period: 2025-2025

Location: Akershus

HELSEFORSKNING-Helseforskning

Kunstig intelligens som støtte i journaldokumentasjon – for økt effektivitet og kvalitet i pasientbehandling

Kunstig intelligens som støtte i journaldokumentasjon – for økt effektivitet og kvalitet i pasientbehandling Helsetjenestene vil stå overfor betydelige utfordringer knyttet til bærekraftutfordringer. I dag bruker høykompetent personell mye tid på journalarbeid i form av skriving, søk etter infor...

Awarded: NOK 0.25 mill.

Project Period: 2025-2025

Location: Buskerud

FORSKNINGSINFRA-FORSKNINGSINFRA

National proton therapy research infrastructure

Starting in March 2025, Norway will offer a new cancer treatment called proton therapy. This type of radiation therapy is particularly important for children and young patients, who currently need to travel abroad to receive it. Proton therapy is gentler on the body compared to traditional x-ray ...

Awarded: NOK 2.0 mill.

Project Period: 2025-2026

Location: Oslo

HELSEFORSKNING-Helseforskning

ROBO - en personlig robotassistent for hjem, sykehus og omsorgsinstitusjoner

Gjennom ROBOprosjektet utvikler og tester vi NEO, en banebrytende robotassistent for helse- og omsorgssektoren, i tråd med Pilot Helses mål om å fremme innovative løsninger. Prosjektet vil samle aktører fra både offentlig og privat sektor, på tvers av forvaltningsnivåer, for å stimulere til tverr...

Awarded: NOK 0.25 mill.

Project Period: 2025-2025

Location: Akershus

NYSKAPNING-NYSKAPNING

Tidligfase teknologioverføring ved OUS

Oslo University Hospital (OUS) has some of the country's leading research groups within medicine and health sciences. Several hundred shared positions between university and hospital give us a unique strength. Our researchers are positive towards commercialization, but there is a need to strength...

Awarded: NOK 14.2 mill.

Project Period: 2025-2026

Location: Oslo

NYSKAPNING-NYSKAPNING

Tidligfase teknologioverføring for forskning og innovasjon i Vestre Viken helseforetak

Vestre Viken is one of Norway’s largest health trusts, with over 10,000 employees delivering healthcare services to 500,000 patients, with a rapidly growing research environment. In 2023, the organization published 188 scientific articles and participated in several national research networks. De...

Awarded: NOK 1.8 mill.

Project Period: 2025-2026

Location: Buskerud

HELSEFORSKNING-Helseforskning

Tegn til Bedring - mer kostnadseffektive videokonsultasjoner i psykisk helse

Tegn til bedring (TTB) er en digitalisert whiteboard/tavle-applikasjon, som erstatter behov for fysisk penn, papir, bilder eller modeller i videokonsultasjoner. Målet er å øke nytteverdien av videokonsultasjoner ved at brukere av TTB kan tegne, skrive, lime inn nettressurser og bilder etc. Bruker...

Awarded: NOK 0.21 mill.

Project Period: 2025-2025

Location: Oslo

HELSEFORSKNING-Helseforskning

Patient-centered care IT

For å møte de ressurs- og bemanningsutfordringene i helsevesenet i Norge, Norden og Europa står overfor i dag, vil PACIT utvikle nye virksomhetsmodeller basert på pasientforløpsmetodikken støttet av nye digitale løsninger. Den tradisjonelle bestiller-utførermodell vil endres til en felles utvikli...

Awarded: NOK 0.25 mill.

Project Period: 2025-2025

Location: Oslo

PESORDNING-PESORDNING

PES Horisont Europa rammebevilgning 2025–2027

Helse Sør-Øst (HSØ) has established strategies and plans for research. All the health enterprises (HF) in HSØ aim to increase their focus on the EU. This is being worked on both locally and through the central research support. The research support unit associated with OUS has a regional responsi...

Awarded: NOK 3.1 mill.

Project Period: 2025-2027

Location: Oslo

HELSEFORSKNING-Helseforskning

Point-of-care quantitative hepatitis B viral load assay

In 2016, the World Health Organization (WHO) endorsed an ambitious plan of eliminating hepatitis B virus (HBV) infection as a public health threat by 2030. A major challenge, however, is the lack of point-of-care (POC) diagnostic tools for HBV DNA viral load, which is required to identify patient...

Awarded: NOK 0.25 mill.

Project Period: 2025-2025

Location: Oslo

HELSEFORSKNING-Helseforskning

Detection, Classification, Characterization and Treatment Monitoring of Tumors by Accessible Epigenetic Classification (DC2M-TAEC)

A correct diagnosis is crucial for predicting prognosis and choosing treatment. Current improvements in our understanding of brain tumor biology has led to an increasing use of epigenetic diagnostics. These diagnostic strategies are based upon identification of the modification done to DNA to reg...

Awarded: NOK 3.4 mill.

Project Period: 2024-2027

Location: Oslo

INNO-OFF-INNO-OFF

«Et intelligent mål på kondisjon» - Kunstig intelligens for å estimere fysisk kapasitet hos pasienter med overvekt og fedme

Fysisk kapasitet, eller kondisjon, er kroppens evne til å oppta oksygen under belastning, og lav fysisk kapasitet er forbundet med like høy dødelighetsrisiko som diabetes, høyt blodtrykk, røyking og fedme. Dette gjør fysisk kapasitet til en viktig helseindikator, spesielt ved forebygging og behan...

Awarded: NOK 0.15 mill.

Project Period: 2024-2025

Location: Vestfold

HELSEFORSKNING-Helseforskning

ISGEDR konferanse Oslo 2025

Prosjektsammendrag: ISGEDR Oslo 2025 Dato: 11.–13. september 2025 Tema: Arvelige øyesykdommer, sjeldne sykdommer, internasjonalt samarbeid, persontilpasset behandling, translasjonsforskning Relevans: Genetiske øyesykdommer rammer barn og voksne og er en viktig årsak til blindhet hos unge. I Norg...

Awarded: NOK 0.15 mill.

Project Period: 2024-2025

Location: Oslo

HELSEFORSKNING-Helseforskning

Læring og mestring 2024: Sammen fremmer vi helse og livskvalitet

På selveste FN-dagen vil konferansen «Læring og mestring 2024: Sammen fremmer vi helse og livskvalitet» sette søkelyset på helsekompetanse, livskvalitet og bærekraft. Som eneste nasjonale møtearena innen lærings- og mestringsfeltet skal konferansen tilrettelegge for kunnskapsdeling, nettverksbygg...

Awarded: NOK 0.15 mill.

Project Period: 2024-2025

Location: Oslo

HELSEFORSKNING-Helseforskning

Moving towards evidence-based treatment strategies for children with juvenile idiopathic arthritis in sustained remission: The MOVE-JIAtrial

In this randomized controlled trial, we aim to optimize the management of patients with juvenile idiopathic arthritis (JIA) who are in stable disease remission. Balancing the risk of JIA flare with the long-term burden of medications and their side effects is a crucial concern for patients, paren...

Awarded: NOK 11.0 mill.

Project Period: 2024-2028

Location: Oslo